| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |